The Pathogenesis of Autoimmune Liver Disease
Related Experiment Video
Updated: Mar 21, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Katherine Arndtz1, Gideon M Hirschfield
1Centre for Liver Research, NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, UK.
Insights
Autoimmune liver diseases (AILD) involve genetic and environmental factors, leading to immune system dysfunction. Understanding these complex pathways is key to developing better treatments for autoimmune hepatitis, PBC, and PSC.
Area of Science:
- Immunology
- Hepatology
- Genetics
Background:
- Autoimmune liver disease (AILD) includes autoimmune hepatitis, primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).
- These conditions contribute significantly to patient morbidity and mortality, highlighting unmet research needs.
- AILD is linked to genetic predisposition, auto-antibodies, and other autoimmune conditions.
Purpose of the Study:
- To explore the genetic and environmental factors contributing to autoimmune liver diseases.
- To understand the immunological mechanisms underlying AILD pathogenesis.
- To identify pathways for improved therapeutic strategies.
Main Methods:
- Review of observational evidence for genetic predisposition.
- Analysis of genetic risk association studies (HLA and non-HLA loci).
- Examination of immunological pathways (e.g., IL-2, IL-12) and environmental triggers.
Main Results:
- Genetic predisposition is evident, with familial clustering of AILD.
- Specific HLA and non-HLA loci are associated with disease development and prognosis.
- Loss of immune tolerance, T-cell mediated injury, and dysregulated immune responses are key immunological themes.
- Cholestasis in PBC and PSC adds complexity to liver injury and fibrosis.
Conclusions:
- AILD results from a combination of genetic susceptibility and environmental exposures, triggering aberrant immune responses in the liver.
- While specific triggers remain elusive, understanding the diverse pathways of liver injury is crucial for developing targeted therapies.
Background:
Autoimmune liver disease (AILD) encompasses 3 main distinct clinical diseases: autoimmune hepatitis, primary biliary cholangitis (formally known as cirrhosis, PBC) and primary sclerosing cholangitis (PSC). These conditions are an important, yet under-appreciated cause of patient morbidity and mortality with ongoing unmet needs for further research and clinical advances.
Key Messages:
There is observational evidence for genetic predisposition, with all 3 conditions being more common in first degree relatives. AILD is associated with the presence of auto-antibodies and higher risks of other non-hepatic auto-immune conditions. Genetic risk association studies have identified HLA and non-HLA risk loci for the development of disease, with some HLA loci providing prognostic information. This re-enforces the concept that genetic predisposition to autoimmunity is important, likely in the context of environmental exposures. Such environmental triggers are unclear but relevant risks include smoking, drug and xenobiotic exposure as well as the complexities of the microbiome. There is evidence for a loss of immune tolerance to self-antigens playing a part in the development of these conditions. In particular the IL-2 and IL-12 regulatory pathways have been implicated in pre-disposing to an unopposed inflammatory response within the liver. Main immunological themes revolve around loss of immune tolerance leading to T-cell mediated injury, imbalance in the regulation of immune cells and defective immune response to foreign antigens. For PBC and PSC, there is then the added complexity of the consequences of cholestasis on hepato-biliary injury, immune regulation and liver fibrosis.
Conclusions:
Whilst specific disease causes and triggers are still lacking, AILD arises on the background of collective genetic and environmental risk, leading to chronic and abnormal hepato-biliary immune responses. Effective and more rational therapy will ultimately be developed when the multiple pathways to liver injury are better understood.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cell-mediated Immune Responses
What is the Immune System?
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

